Abstract
Background: the cutaneous manifestations of COVID-19 are increasingly reported and they are important clues
for early detection of SARS-CoV-2 infection.
Objective: To describe the different morphologies of skin and/or mucosal lesions associated with confirmed
COVID-19 adult patients who have been admitted to the main quarantine hospital in Dhi-Qar province.
Patients and methods: All confirmed COVID-19 patients were examined for mucosal and/or cutaneous lesion,
and those who had such manifestations were evaluated and subjected to a detailed history, a complete physical
examination and photography for documentation. The patients were classified into five groups according to
lesions’ morphology; maculopapular, urticarial, pustular and papulovesicular, vasculitic and miscellaneous
groups.
Results: Out of 3554 confirmed COVID-19 patients only 157 showed mucocutaneous manifestations, of
them116 patients were excluded for many reasons as cutaneous adverse drug reactions (CADR), other
infections …etc. The remaining 41 patients who represent (1.15%) were included and classified into;
maculopapular (29.26%), urticarial (24.39%), pustular and papulovesicular (17.07%), vasculitic (14.63%) and
miscellaneous (14.63%).
Conclusions: This study has shown that there are many cutaneous manifestations in COVID-19 disease that
may differ from one country to another, while some are constant around the globe, so it is important for any
doctor, not just the dermatologists, to recognize and bear these presentations in mind during this pandemic for
early detection, better treatment and prevention of SARS-CoV-2 infection, hopefully that one day this pandemic
is over by the collaboration of all of us.
for early detection of SARS-CoV-2 infection.
Objective: To describe the different morphologies of skin and/or mucosal lesions associated with confirmed
COVID-19 adult patients who have been admitted to the main quarantine hospital in Dhi-Qar province.
Patients and methods: All confirmed COVID-19 patients were examined for mucosal and/or cutaneous lesion,
and those who had such manifestations were evaluated and subjected to a detailed history, a complete physical
examination and photography for documentation. The patients were classified into five groups according to
lesions’ morphology; maculopapular, urticarial, pustular and papulovesicular, vasculitic and miscellaneous
groups.
Results: Out of 3554 confirmed COVID-19 patients only 157 showed mucocutaneous manifestations, of
them116 patients were excluded for many reasons as cutaneous adverse drug reactions (CADR), other
infections …etc. The remaining 41 patients who represent (1.15%) were included and classified into;
maculopapular (29.26%), urticarial (24.39%), pustular and papulovesicular (17.07%), vasculitic (14.63%) and
miscellaneous (14.63%).
Conclusions: This study has shown that there are many cutaneous manifestations in COVID-19 disease that
may differ from one country to another, while some are constant around the globe, so it is important for any
doctor, not just the dermatologists, to recognize and bear these presentations in mind during this pandemic for
early detection, better treatment and prevention of SARS-CoV-2 infection, hopefully that one day this pandemic
is over by the collaboration of all of us.
Keywords
Covid-19
Novel coronavirus
SARS-CoV-2.